Distribution and Protein Binding

Distribution describes how a drug, once in the systemic circulation, partitions between blood and the various tissues of the body. Many drugs bind reversibly to plasma proteins such as albumin and alpha-1-acid glycoprotein, and because only the unbound (free) drug can cross membranes and act at its target, the extent of binding shapes both distribution and effect.

Definition

Distribution is the reversible transfer of a drug between the systemic circulation and the tissues; the apparent volume of distribution (Vd) is the proportionality constant relating the total amount of drug in the body to the measured plasma concentration. Plasma protein binding is the reversible association of a drug with circulating proteins, leaving an unbound fraction free to distribute and act.

Scope

This topic covers the determinants of drug distribution, the apparent volume of distribution as a summary parameter, the principles of reversible plasma-protein binding, and the relationship between free and total drug concentration. It is a reference and educational entry and does not provide individualized dosing or monitoring advice.

Core questions

• What physicochemical and physiological factors govern how widely a drug distributes?
• What does the apparent volume of distribution represent and how is it interpreted?
• How does reversible plasma-protein binding influence the free drug concentration?
• When does altered protein binding meaningfully change drug exposure or effect?

Key concepts

• Apparent volume of distribution (Vd)
• Unbound (free) fraction
• Plasma proteins: albumin and alpha-1-acid glycoprotein
• Free drug hypothesis
• Tissue partitioning and lipophilicity
• Perfusion- versus permeability-limited distribution
• Blood-brain barrier

Mechanisms

After entering the circulation, a drug distributes into tissues at a rate set by regional blood flow and a magnitude set by its lipophilicity and binding to plasma and tissue components. The apparent volume of distribution links the plasma concentration to the total amount in the body; extensive tissue binding produces a large Vd, while confinement to plasma produces a small one. Reversible binding to plasma proteins establishes an equilibrium between bound and unbound drug, and because only unbound drug crosses membranes, the free fraction is the pharmacologically relevant quantity. For drugs eliminated with a low extraction ratio, changes in binding can alter the relationship between total and unbound concentration.

Clinical relevance

The volume of distribution and protein binding help explain differences in how drugs partition and why total concentrations may not reflect active drug, which is relevant to interpreting therapeutic drug monitoring results. This entry presents general principles for educational reference and is not a basis for dosing or treatment decisions.

Evidence & guidelines

The principles are codified in standard clinical pharmacokinetics texts; analytical and regulatory guidance addresses the measurement of unbound drug fractions in exposure assessment.

History

The apparent volume of distribution and the free drug concept developed as pharmacokinetics matured into a quantitative discipline. Rowland and Benet's clearance framework clarified how distribution and binding parameters fit alongside clearance in describing the concentration-time profile, and the free drug hypothesis became a central organizing principle of distribution.

Key figures

• Malcolm Rowland
• Leslie Benet
• Thomas Tozer

Seminal works

• rowland-1973

Frequently asked questions

Why can the volume of distribution exceed total body water?

The volume of distribution is an apparent, not a physical, volume; extensive binding to tissues lowers the plasma concentration relative to the amount in the body, producing a calculated volume far larger than any real body compartment.

Why does the unbound fraction of a drug matter?

Only unbound drug can cross membranes, reach its target, and be eliminated, so the free concentration, rather than the total concentration, generally drives the pharmacological effect.